Work

Phase I study of oral selective c-Met inhibitor EMD 1214063 in pts with advanced solid tumors.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.2506

Authors: Gerald Steven Falchook, David S. Hong, Hesham M. Amin, Siqing Fu, Sarina Anne Piha-Paul, Filip Janku, Vivek Subbiah, Aung Naing, Jennifer J. Wheler, Manfred B. Klevesath, Karola Köhler, Andreas Johne, Friedhelm Bladt, Razelle Kurzrock

Institutions: The University of Texas MD Anderson Cancer Center, Merck KGaA, Darmstadt (Germany)

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2602571572

Cites:

Cited by: 3

Related to: 10